Medigene AG: Leader in T Cell immunology. TCR targeting PRAME (AML, MDS, MM) entered clinic March 2018. CTA submitted for TCR targeting MAGE-A1 (MM, liver, and lung cancer); several add'l undisclosed targets & indications in PC dev't. DC vax in ongoing Ph 1/2; final readout in 2019. Lucrative R&D collaboration w. bluebird bio (BLUE).
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
Europe
Clinical Stage
Phase l or ll
Disease Space
Immunotherapy, Oncology
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Europe, Public
Market Cap
100MM - 500MM
Therapeutic Modalities
Antibodies, Cell Therapy
Website:
Address:
Lochhamer Str. 11
Planegg-Martinsried, 82152
Germany

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.

Upcoming Company Event Participation

Solebury Trout Clients at Jefferies

New York, NY, United States, June 4 – June 7, 2019

European Biotech Investor Day 2019

New York City, August 1, 2019

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2017 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.